Drug intelligence / Profile preview

schwann cell-derived exosomal vesicles

Development stage
Preclinical
Modality
Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Administration
Intravenous, Intrathecal, Local Injection, Intranasal
01

Overview

Schwann cell-derived exosomal vesicles are nanoscale extracellular vesicles (exosomes) secreted by Schwann cells—the myelinating glia of the peripheral nervous system. These vesicles range from 30–150 nm in diameter and contain a variety of bioactive molecules including miRNAs, mRNAs, proteins, and lipids. They play a crucial role in intercellular communication and have demonstrated significant therapeutic potential for tissue regeneration and repair—particularly in neurological injuries such as spinal cord injury (SCI), traumatic brain injury (TBI), and peripheral nerve damage[1][2][5][6]. Schwann cell-derived exosomal vesicles promote axonal regeneration by modulating cellular processes like proliferation, differentiation, angiogenesis, neuroprotection, and inflammation reduction[2][4][5]. Their small size allows them to cross the blood-brain barrier efficiently with low immunogenicity compared to whole-cell therapies. Additionally, they can be engineered for targeted delivery or loaded with therapeutic agents[6].

Other names
schwann cell-derived exosomesSCEVsSC-ExoshSC-Exos

Beyond the preview

Go deeper on schwann cell-derived exosomal vesicles.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on schwann cell-derived exosomal vesicles.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call